ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
Dow Jones
44.303,40
-0,99%
Euro vs US Dollar
1,03256
-0,57%
Bitcoin
95.968,63
-0,63%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Terns Pharmaceuticals Inc (TERN) Börsenkurse

Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc (TERN)

Tern Plc
4,525
-0,14
( -3,00% )
Aktualisiert: 21:50:06
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
4,525
Gebot
4,52
Fragen
4,53
Volumen
529.239
4,46 Tagesbereich 4,765
4,165 52-Wochen-Bereich 11,40
Marktkapitalisierung
384,348M
Handelsende
4,665
Handelsbeginn
4,63
Letzte Trade
173
@
4.525
Letzter Handelszeitpunkt
21:50:17
Finanzvolumen
US$ 2.429.117
VWAP
4,5898
Durchschnittliches Volumen (3 Mio.)
1.897.355
Ausgegebene Aktien
84.938.855
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,25
Gewinn pro Aktie (EPS)
-1,06
Erlöse
-
Nettogewinn
-90,21M

Über Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.ternspharma.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Terns Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TERN. The last closing price for Terns Pharmaceuticals was US$4,67. Over the last year, Terns Pharmaceuticals shares have traded in a share price range of US$ 4,165 to US$ 11,40.

Terns Pharmaceuticals currently has 84.938.855 shares in issue. The market capitalisation of Terns Pharmaceuticals is US$396,24 million. Terns Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.25.

TERN Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

23 Stunden vor
Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

05 Februar 2025
Edgar (US Regulatory)

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

FOSTER CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

05 Februar 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

04 Februar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 Februar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 Februar 2025
Edgar (US Regulatory)

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

03 Februar 2025
GlobeNewswire Inc.

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

FOSTER CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

08 Januar 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

07 Januar 2025
Edgar (US Regulatory)

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

02 Januar 2025
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.15-3.208556149734.6754.7454.22519944174.53277016CS
4-0.635-12.30620155045.165.164.16520249014.53578562CS
12-1.985-30.49155145936.517.464.16518973555.57086122CS
26-2.735-37.67217630857.2611.44.16518779727.25255931CS
52-0.845-15.73556797025.3711.44.16514637267.18246423CS
1560.1954.503464203234.3314.04351.457610377.16621801CS
260-12.425-73.303834808316.9528.361.455937297.53140668CS

TERN - Frequently Asked Questions (FAQ)

What is the current Terns Pharmaceuticals share price?
The current share price of Terns Pharmaceuticals is US$ 4,525
How many Terns Pharmaceuticals shares are in issue?
Terns Pharmaceuticals has 84.938.855 shares in issue
What is the market cap of Terns Pharmaceuticals?
The market capitalisation of Terns Pharmaceuticals is USD 396,24M
What is the 1 year trading range for Terns Pharmaceuticals share price?
Terns Pharmaceuticals has traded in the range of US$ 4,165 to US$ 11,40 during the past year
What is the PE ratio of Terns Pharmaceuticals?
The price to earnings ratio of Terns Pharmaceuticals is -4,25
What is the reporting currency for Terns Pharmaceuticals?
Terns Pharmaceuticals reports financial results in USD
What is the latest annual profit for Terns Pharmaceuticals?
The latest annual profit of Terns Pharmaceuticals is USD -90,21M
What is the registered address of Terns Pharmaceuticals?
The registered address for Terns Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Terns Pharmaceuticals website address?
The website address for Terns Pharmaceuticals is www.ternspharma.com
Which industry sector does Terns Pharmaceuticals operate in?
Terns Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AALAmerican Airlines Group Inc
US$ 0,00
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,00
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0,00
(0,00%)
0
AADIAadi Bioscience Inc
US$ 0,00
(0,00%)
0
AACGATA Creativity Global
US$ 0,00
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 0,00
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,00
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0,00
(0,00%)
0
AADIAadi Bioscience Inc
US$ 0,00
(0,00%)
0
AACGATA Creativity Global
US$ 0,00
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 0,00
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,00
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0,00
(0,00%)
0
AADIAadi Bioscience Inc
US$ 0,00
(0,00%)
0
AACGATA Creativity Global
US$ 0,00
(0,00%)
0

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
TERN
Terns Pharmaceuticals
BIT
P1T8L0
BNP Paribas Issuance
BIT
UV8CHG
UniCredit Bank
BIT
UB4QD6
Unicredit Bank
BIT
JREC
Exchange Traded Fund Jpm...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten